Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report. Iriyama H, Iwase M, Takano Y, Takeuchi D, Ichikawa T, Ohata R, Ozaki Y, Yamamoto M, Inaguma G, Torii N, et al. Surg Case Rep. 2026; 12(1). PMID: 42741082. Abstract CommentRecommendBookmarkWatch
